WW
GILD icon

Winnow Wealth’s Gilead Sciences GILD Stock Holding History

Winnow Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
8,424
-187
-2% -$24.6K 0.72% 36
2026
Q1 		$1.2M Sell
8,611
-493
-5% -$69K 0.93% 18
2025
Q4 		$1.12M Sell
9,104
-1,367
-13% -$166K 0.83% 16
2025
Q3 		$1.16M Buy
+10,471
New +$1.19M 0.91% 25
2025
Q2 		– Sell
-9,903
Closed -$1.11M – 378
2025
Q1 		$1.11M Sell
9,903
-1,312
-12% -$135K 1.02% 15
2024
Q4 		$1.01M Buy
+11,215
New +$1.01M 1.01% 16

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Winnow Wealth's GILD Position: Q2 2026 in Review

Winnow Wealth reduced its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, selling an estimated $24.6K and leaving 8,424 shares worth $1.06M. The position accounts for 0.72% of the portfolio, ranked #36.

Winnow Wealth first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.2M in Q1 2026. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Winnow Wealth held 8,424 shares of Gilead Sciences worth $1.06M as of Q2 2026.
  • Winnow Wealth sold 187 Gilead Sciences shares in Q2 2026, an estimated $24.6K.
  • Gilead Sciences made up 0.72% of Winnow Wealth's portfolio in Q2 2026, its #36 holding.
  • Winnow Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Winnow Wealth's Gilead Sciences position peaked at $1.2M in Q1 2026.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Winnow Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.